Governance
In News: MSMEs have availed the benefit under erstwhile PTUAS scheme.
PTUAS scheme:
- PTUAS is a credit linked scheme.
- It is a sub-scheme under the Scheme – Strengthening of Pharmaceutical Industry (SPI).
- SIDBI is the Project Management Consultant (PMC) of the scheme
- Aim – to facilitate MSMEs of proven track record to meet national and international regulatory standards (WHO-GMP or Schedule-M)
- It includes interest subvention or capital subsidy on their capital loans, which will further facilitate the growth in volumes as well as in quality
- It is envisaged to support about 400 Pharma MSME units under this sub-scheme during the scheme tenure.
- Further, one national and 10 State level outreach events were conducted, involving the State Governments and Pharma Industry Associations for maximum outreach and awareness for larger participation by Pharma MSME industries to avail the scheme benefits.
- Details are available at https://spi.udyamimitra.in
SPI (umbrella) scheme:
- It was launched in July 2022.
- The SPI has a financial outlay of Rs. 500 crores and with a tenure from FY 2021-2022 to FY 2025-26
- Aim of SPI
- to provide infrastructure support for pharma MSMEs in clusters
- to address the issues of technology upgradation of individual pharma MSMEs
- It has following three components
- Assistance to Pharmaceutical Industry for Common Facilities (API-CF)
- Pharmaceutical Technology Upgradation Assistance Scheme (PTUAS)
- Pharmaceutical & Medical Devices Promotion and Development Scheme (PMPDS)
Source: PIB
Previous Year Question
Q.1) With reference to ‘Stand Up India Scheme’, which of the following statements is/are correct? (2016)
- Its purpose is to promote entrepreneurship among SC/ST and women entrepreneurs.
- It provides for refinance through SIDBI.
Select the correct answer using the code given below.
- 1 only
- 2 only
- Both 1 and 2
- Neither1 nor 2
